Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Until now, our understanding of human brain pharmacology has depended on indirect assessments or animal models. The advent of pharmacological functional magnetic resonance imaging (phMRI) has enabled researchers to focus directly on human pharmacology and brain function. Functional MRI, with its increased spatial and temporal resolution, has a further advantage over other neuroimaging methods in that being totally noninvasive, it allows serial, longitudinal studies to be performed on the same subject. This opens the door to a new era of phMRI, as the effects of drugs can be readily monitored in one subject (control or patient) overtime. In addition, sophisticated paradigms can be developed that can isolate specific brain regions of activation. These regions can then be subsequently targeted and challenged with appropriate drugs. This allows for a "battery" of paradigms aimed at determining a drug's mechanism and site of action, which would be valuable for drug development and discovery.

Original publication

DOI

10.1106/QACM-FBX4-90UK-FRW6

Type

Journal article

Journal

Journal of Pharmacy Practice

Publication Date

17/12/2001

Volume

14

Pages

368 - 375